Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged - Al Jazeera English
The move disappointed investors who were hoping products would continue to drive growth.
Pfizer Inc. kept its outlook for annual sales of its Covid-19 vaccine and treatment, disappointing investors who looked for the products to continue driving growth.
Through mid-April, Pfizer said it… [+4330 chars]
Read More
Other Stories in Business
- Apple CEO says looking into possibility of building manufacturing facility in Indonesia By Reuters
- Apple CEO says looking into possibility of building manufacturing facility in Indonesia By Reuters
- US and allies plan more Iran sanctions; Israel war cabinet to meet again By Reuters
- Food inflation test: Cloud delivery could help
- Cathie Wood's Ark Invest Continues To Shed Coinbase, Nvidia Shares - ARK Genomic Revolution ETF (BATS:ARKG)
- Syscoin $SYS Staking - Making Money Made Simple
- Economy Minister Rafizi’s shocking Raya break-in shocks netizens
- Revolut gets in-principle approval from RBI for Prepaid Payment Instruments licence
- BDC Weekly Review: Why BDCs Want To Issue Stock
